Monday, February 4, 2013

FDA finds contaminated vials, bacteria and mold at New England Compounding Center | Synopsis

FDA finds contaminated vials, bacteria and mold at New England Compounding Center

FDA Intends to Remove Unapproved Drugs from Market
FDA Intends to Remove Unapproved Drugs from Market by The U.S. Food and Drug Administration
License (according to Flickr): United States Government Work
Excerpt:

The U.S. Food and Drug Administration Friday released a report of its observations from an inspection of the New England Compounding Center, the Framingham, Mass. , facility tied to a nationwide fungal meningitis outbreak. Up until now, 331 cases of fungal meningitis have actually been discovered in 18 states, consisting of 25 deaths, according to the Centers for Disease Control and Prevention. The most recent state to state an infection was South Carolina, and the latest death was stated in Tennessee. Seven other peripheral joint infections from injections given to joints such as the knees, hips, shoulders and elbows, have actually also been linked to the outbreak. Meningitis: Fungus discovered in steroids Throughout an FDA inspection of the facility on Oct.

People:

Steven Lynn

Overall Sentiment: 0.404468

Relevance: 0.220338

Additional Info:

StateOrCounty: Mass.

Overall Sentiment: 0

Relevance: 0.366712

Disambiguation: Location | PoliticalDistrict | AdministrativeDivision | GovernmentalJurisdiction | USStateReferences:

HealthCondition: meningitis

Overall Sentiment: -0.341332

Relevance: 0.695083

Drug: methylprednisolone

Overall Sentiment: -0.123679

Relevance: 0.317923

Organization: New England Compounding Center

Overall Sentiment: 0.0556564

Relevance: 0.838528

Organization: FDA

Overall Sentiment: 0.0164527

Relevance: 0.50579

Organization: U.S. Food and Drug Administration

Overall Sentiment: 0.0595192

Relevance: 0.451452

URL Header

No comments:

Post a Comment